The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XV.z

Path: Obliterative (constrictive) bronchiolitis (see also IVc, IVn)

Publications

Chang YL, Chen JS, Wu HD, Lee YC

Retransplantation of contralateral lung in a patient with Sauropus androgynus-induced bronchobronchiolitis obliterans.

Transplantation proceedings. 2000;32(7):2432-4

Wang JS, Tseng HH, Lai RS, Hsu HK, Ger LP

Sauropus androgynus-constrictive obliterative bronchitis/bronchiolitis--histopathological study of pneumonectomy and biopsy specimens with emphasis on the inflammatory process and disease progression.

Histopathology. 2000;37(5):402-10

Chang YL, Yao YT, Wang NS, Lee YC

Segmental necrosis of small bronchi after prolonged intakes of Sauropus androgynus in Taiwan.

American journal of respiratory and critical care medicine. 1998;157(2):594-8

Chang H, Wang JS, Tseng HH, Lai RS, Su JM

Histopathological study of Sauropus androgynus-associated constrictive bronchiolitis obliterans: a new cause of constrictive bronchiolitis obliterans.

The American journal of surgical pathology. 1997;21(1):35-42